pharmeasy: PharmEasy CEO on 90% drop in share price: ‘Not a valuation cut but a chance to reward shareholders.’
Siddharth Shah, CEO, Pharmeasy; image credit: ET Bangalore Synopsis Pharmeasy’s INR 3,500 crore-rights issue has been “oversubscribed”, CEO Siddharth Shah says. Shah also talks about the company’s focus on repaying …